Do low SHBG and high uric acid predict insulin resistance and future type 2 diabetes even with normal fasting glucose?

The relationship between sex hormone-binding globulin (SHBG), serum uric acid (SUA), and metabolic health represents a critical early-warning system for metabolic dysfunction, often manifesting before fasting glucose levels cross clinical thresholds.

Clinical effectiveness and predictive value

Longitudinal evidence confirms that both low SHBG and high SUA are robust, independent predictors of insulin resistance and incident type 2 diabetes (T2D) in normoglycemic individuals.

• SHBG: In healthy, non-diabetic men, baseline SHBG levels are inversely correlated with HOMA-IR (homeostatic model assessment of insulin resistance). Individuals in the lowest quartiles of SHBG exhibit significantly higher hazard ratios for developing T2D, even after adjusting for BMI and body fat distribution. Mendelian randomization studies suggest this relationship may be causal rather than just correlative.
• Uric Acid: Data from the Framingham Heart Study indicates a 15–20% increase in T2D risk for every one-standard-deviation increase in SUA. A meta-analysis of 16 studies reported a pooled relative risk of 1.13, reinforcing SUA as an independent risk factor that often precedes the transition from normal to impaired fasting glucose.

Mechanistic explanations

The associations are driven by complex biochemical feedback loops and direct cellular signaling interference:

• SHBG suppression: Hyperinsulinemia, a hallmark of early insulin resistance, directly suppresses the hepatic synthesis of SHBG. Consequently, declining SHBG levels serve as a sensitive proxy for systemic and hepatic insulin dysregulation.
• Uric acid and insulin signaling: Elevated SUA promotes hepatic insulin resistance by triggering the proteasomal degradation of insulin receptor substrate 2 (IRS2). It also activates the NLRP3 inflammasome, leading to the production of inflammatory cytokines that disrupt insulin signaling.
• Vascular and oxidative stress: High SUA reduces nitric oxide bioavailability, which impairs endothelial function and the delivery of glucose to peripheral tissues. Within macrophages and hepatocytes, uric acid acts as a pro-oxidant, further interrupting insulin signaling via the TLR and Akt pathways.

Bottom line

Lower SHBG and higher uric acid levels are clinically significant markers of insulin resistance and future diabetes risk. They provide actionable insight into metabolic health even when standard markers, like fasting glucose, remain within the normal range.